Absolute numbers of distinct populations of CD4+ T cells from FVIII plasmid + anti-CD3– and FVIII plasmid only–treated mice at day 8, week 4, and week 6 after treatment
Treatment group/cell type . | Day 8 . | Week 4 . | Week 6 . |
---|---|---|---|
FVIII plasmid only | |||
CD4+ cells | 10.8 (± 2.5) × 106 | 11.0 (± 1.8) × 106 | 11.4 (± 1.0) × 106 |
CD4+Foxp3+ cells | 1.43 (± 0.20) × 106 | 1.32 (± 0.30) × 106 | 1.35 (± 0.30) × 106 |
CD4+CD25+Foxp3+ cells | 1.1 (± 0.09) × 106 | 1.0 (± 0.24) × 106 | 1.2 (± 0.1) × 106 |
CD4+CD25−Foxp3+ cells | 1.7 (± 0.37) × 105 | 1.9 (± 0.03) × 105 | 1.8 (± 0.23) × 105 |
FVIII plasmid + anti-CD3 | |||
CD4+ cells | 4.2 (± 1.1) × 106* | 7.7 (± 0.8) × 106* | 10.4 (± 1.5) × 106 |
CD4+Foxp3+ cells | 1.28 (± 0.16) × 106 | 1.38 (± 0.13) × 106 | 1.4 (± 0.1) × 106 |
CD4+CD25+Foxp3+ cells | 0.74 (± 0.17) × 106* | 1.0 (± 0.1) × 106 | 1.1 (± 0.08) × 106 |
CD4+CD25−Foxp3+ cells | 5.6 (± 1.0) × 105† | 2.1 (± 0.02) × 105 | 1.9 (± 0.13) × 105 |
Treatment group/cell type . | Day 8 . | Week 4 . | Week 6 . |
---|---|---|---|
FVIII plasmid only | |||
CD4+ cells | 10.8 (± 2.5) × 106 | 11.0 (± 1.8) × 106 | 11.4 (± 1.0) × 106 |
CD4+Foxp3+ cells | 1.43 (± 0.20) × 106 | 1.32 (± 0.30) × 106 | 1.35 (± 0.30) × 106 |
CD4+CD25+Foxp3+ cells | 1.1 (± 0.09) × 106 | 1.0 (± 0.24) × 106 | 1.2 (± 0.1) × 106 |
CD4+CD25−Foxp3+ cells | 1.7 (± 0.37) × 105 | 1.9 (± 0.03) × 105 | 1.8 (± 0.23) × 105 |
FVIII plasmid + anti-CD3 | |||
CD4+ cells | 4.2 (± 1.1) × 106* | 7.7 (± 0.8) × 106* | 10.4 (± 1.5) × 106 |
CD4+Foxp3+ cells | 1.28 (± 0.16) × 106 | 1.38 (± 0.13) × 106 | 1.4 (± 0.1) × 106 |
CD4+CD25+Foxp3+ cells | 0.74 (± 0.17) × 106* | 1.0 (± 0.1) × 106 | 1.1 (± 0.08) × 106 |
CD4+CD25−Foxp3+ cells | 5.6 (± 1.0) × 105† | 2.1 (± 0.02) × 105 | 1.9 (± 0.13) × 105 |